Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori
- 1 March 2000
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 38 (3) , 243-270
- https://doi.org/10.2165/00003088-200038030-00004
Abstract
As Helicobacter pyloriplays an important role in the aetiopathogenesis of peptic ulcer, therapeutic strategies aimed at maintaining long term remission have shifted from the control of intragastric...Keywords
This publication has 206 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of H2-Receptor Antagonists in Patients with Renal InsufficiencyClinical Pharmacokinetics, 1993
- Pharmacokinetic Study of Omeprazole in Elderly Healthy VolunteersClinical Pharmacokinetics, 1992
- Clinical Pharmacokinetics of Metronidazole and Other Nitroimidazole Anti-InfectivesClinical Pharmacokinetics, 1992
- AzithromycinDrugs, 1992
- OmeprazoleDrugs, 1991
- Colloidal Bismuth SubcitrateDrugs, 1988
- Pharmacokinetics of Tinidazole in Male and Female SubjectsThe Journal of Clinical Pharmacology, 1982
- Absorption of salicylate and bismuth from a bismuthsubsalicylate-containing compound (Pepto-Bismol)The Journal of Pediatrics, 1981
- Interactions with the Absorption of TetracyclinesDrugs, 1976
- Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with referencesJournal of Pharmacokinetics and Biopharmaceutics, 1975